<?xml version="1.0" encoding="utf-8"?>
<XML>
<JOURNAL>
<YEAR>2024</YEAR>
<VOL>22</VOL>
<NO>1</NO>
<MOSALSAL>0</MOSALSAL>
<PAGE_NO>80</PAGE_NO>


<ARTICLES>

	<ARTICLE> 
		<TitleF>Prediction of underweight, short stature, and microcephaly based on brain diffusion-weighted imaging sequence in neonates with stage.2 of hypoxic-ischemic encephalopathy: A follow-up study</TitleF>
		<TitleE>پیش‌بینی کم‌وزنی، کوتاه‌قدی و میکروسفالی بر اساس توالی تصویربرداری d‌iffusion weighted imaging مغز در نوزادان با مرحله 2 انسفالوپاتی هیپوکسیک-ایسکمیک: یک مطالعه از نوع پیگیری</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: کاهش اکسیژن&#173;رسانی و جریان خون مغز طبق تعریف انسفالوپاتی هیپوکسیک-ایسکمیک (HIE) در 1 تا 8 تولد از هر 1000 تولد کامل در کشورهای توسعه&#173;یافته و تا 26 مورد در هر 1000 در کشورهای در حال توسعه رخ می&#173;دهد.
هدف: وضعیت رشد بازماندگان تولد HIE به اندازه کافی ارزیابی نشده است. در این مطالعه پارامترهای رشد (وزن، قد و دور سر) نوزادان مبتلا به سرنات مرحله 2 HIE در ماه&#8204;های 6، 10 و 12 و ارتباط آن با یافته&#8204;های تصویربرداری وزنی با انتشار مغز نوزادان (DWI) مورد بررسی قرار گرفت.
مواد و روش&#173; ها: پارامترهای رشد 35 نوزاد با سن حاملگی بالاتر از 34 هفته که با مرحله 2 HIE در بخش مراقبت&#8204;های ویژه نوزادان بیمارستان شهید صدوقی یزد از اسفند 1399 تا اسفند 1400 بستری شده بودند، از پرونده بیماران استخراج شد. ارتباط با یافته&#173;های توالی DWI مغز نوزادان ارزیابی شد.
نتایج: 15 دختر و 20 پسر با میانگین وزن هنگام تولد 8/221 &#177; 3/2880 گرم مورد بررسی قرار گرفتند. تصویربرداری رزونانس مغناطیسی معمولی (MRI) و DWI در 6 نوزاد (1/%17) و 18 نوزاد (4/%51) غیرطبیعی بود. غیرطبیعی&#173;ترین یافته DWI سیگنال بالا در گانگلیون قاعده/تالاموس در 9 نوزاد (7/%25) بود. DWI غیرطبیعی در نوزادان مبتلا به تشنج و در نوزادان کم&#173;وزن بیشتر است. روزهای بستری در نوزادان با DWI غیرطبیعی طولانی&#173;تر بود. میکروسفالی در&#160;&#160;&#160; &#160;12 ماهگی در کودکان مبتلا به DWI غیرطبیعی بیشتر بود.
نتیجه&#173; گیری: در بازماندگان HIE نوزادان متوسط، توالی غیرطبیعی DWI مغز ممکن است رشد نامناسب سر را پیش&#8204;بینی کند و برای بهبود رشد نیاز به مداخلات پزشکی و تغذیه&#8204;ای دقیق دارند.
&#160;</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Hypoxic-ischemic encephalopathy (HIE), caused due to reduced oxygenation and brain blood flow, occurs in 1-8 per 1000 live full-term births in developed countries and up to 26 per 1000 live in the developing world. The growth status of survivors of birth HIE has not been evaluated sufficiently.
Objective: This study evaluated, the growth parameters (weight, height, and head circumference) of neonates with Sarnat stage.2 of HIE at 6, 10, and 12 months and its relationship with findings of neonatal brain diffusion-weighted imaging (DWI) sequence.
Materials and Methods: Medical records and growth parameters of 35 neonates with gestational age &#62; 34 wk who were admitted with stage.2 of HIE in Neonatal Intensive Care Unit of Shahid Sadoughi hospital, Yazd, Iran from March 2021-March 2022, and its relationship with neonatal brain DWI sequence finding was evaluated.
Results: 15 girls and 20 boys with a mean birth weight of 2880.3 &#177; 221.8 gr were evaluated. Conventional magnetic resonance imaging and DWI were found to be abnormal in 6 (17.1%) and 18 neonates (51.4%). The most abnormal finding of DWI was high signal in basal ganglia/thalamus in 9 neonates (25.7%). Abnormal DWI is more frequent in neonates with seizures and low birth weight. Hospital stay days were more prolonged in neonates with abnormal DWI. Microcephaly at 12 months was more frequent in children with abnormal DWI.
Conclusion: In survivors of moderate neonatal HIE, abnormal brain DWI sequence might predict inappropriate head growth, and need close medical and nutritional interventions for growth improvement.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>1</FPAGE>
			<TPAGE>8</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2023/06/26
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1402/4/5
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2023/12/25
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1402/10/4
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Mohammad</Name>
				<MidName></MidName>
				<Family>Golshan Tafti</Family>
				<NameE>Mohammad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Golshan Tafti</FamilyE>
				<Organizations>
				<Organization>Department of Pediatrics, Ali-ebn-Abitaleb School of Medicine, Islamic Azad University, Yazd Branch, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>mgolshan035@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Marjan</Name>
				<MidName></MidName>
				<Family>Jafari</Family>
				<NameE>Marjan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Jafari</FamilyE>
				<Organizations>
				<Organization>Department of Neonatology, Shahid Beheshti Hospital, Isfahan University of Medical Sciences, Isfahan, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>dr.marjanjafari@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Seyed Reza</Name>
				<MidName></MidName>
				<Family>Mirjalili</Family>
				<NameE>Seyed Reza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mirjalili</FamilyE>
				<Organizations>
				<Organization>Department of Neonatology, Mother and Newborn Health Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>dr_sr_mirjalili@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Razieh</Name>
				<MidName></MidName>
				<Family>Fallah</Family>
				<NameE>Razieh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Fallah</FamilyE>
				<Organizations>
				<Organization>Department of Pediatrics, Children Growth Disorder Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>dr.raziehfallah@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Farimah</Name>
				<MidName></MidName>
				<Family>Shamsi</Family>
				<NameE>Farimah</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Shamsi</FamilyE>
				<Organizations>
				<Organization>Center for Healthcare Data Modeling, Department of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>farimahshamssi@gmail.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Hypoxic ischemia encephalopathy</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Magnetic resonance imaging</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Diffusion weighted imaging</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Microcephaly</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Underweight.</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>هایپوکسیک ایسکمیک انسفالوپاتی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تصویربرداری رزونانس مغناطیسی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تصویربرداری با وزن انتشار</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>میکروسفالی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>کم وزنی.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	El-Mazary AAM, Nasif KhA, Abdel-Hakeem GL, Sherif T, Farouk E, El-Gezawy EM. Adiponectin, leptin and insulin levels at birth and in early postnatal life in neonates with hypoxic ischemic encephalopathy. J Diabetes Metab Disord 2015; 14: 87.##2.	Groenendaal F, de Vries LS. Fifty years of brain imaging in neonatal encephalopathy following perinatal asphyxia. Pediatr Res 2017; 81: 150-155.##3.	Bano Sh, Chaudhary V, Garga UCh. Neonatal hypoxic-ischemic encephalopathy: A radiological review. J Pediatr Neurosci 2017; 12: 1-6.##4.	Rana L, Sood D, Chauhan R, Shukla R, Gurnal P, Nautiyal H, et al. MR imaging of hypoxic ischemic encephalopathy - distribution patterns and ADC value correlations. Eur J Radiol Open 2018; 5: 215-220.##5.	Gunn AJ, Thoresen M. Neonatal encephalopathy and hypoxic-ischemic encephalopathy. Handb Clin Neurol 2019; 162: 217-237.##6.	Walas W, Wilińska M, Bekiesińska-Figatowska M, Halaba Z, Śmigiel R. Methods for assessing the severity of perinatal asphyxia and early prognostic tools in neonates with hypoxic-ischemic encephalopathy treated with therapeutic hypothermia. Adv Clin Exp Med 2020; 29: 1011-1016.##7.	Cascio A, Ferrand A, Racine E, St-Hilaire M, Sanon PN, Gorgos A, et al. Discussing brain magnetic resonance imaging results for neonates with hypoxic-ischemic encephalopathy treated with hypothermia: A challenge for clinicians and parents. eNeurologicalSci 2022; 29: 100424.##8.	Fallah R, Akhavan Karbasi S, Galalian MT, Dehghani-Firouzabadi R. Comparison of developmental status of 5-year-old singleton children born through assisted and natural conceptions. Iran J Reprod Med 2013; 11: 365-370.##9.	Karimi M, Fallah R, Dehghanpoor A, Mirzaei M. Developmental status of 5-year-old moderate low birth weight children. Brain Dev 2011; 33: 651-655.##10.	Islami Z, Fallah R, Mosavian T, Pahlavanzadeh MR. Growth parameters of NICU admitted low birth weight preterm neonates at corrected ages of 6 and 12 month. Iran J Reprod Med 2012; 10: 459-464.##11.	Ashwal S, Michelson D, Plawner L, Dobyns WB, Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Practice parameter: Evaluation of the child with microcephaly (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2009; 73: 887-897.##12.	Shankaran S, Pappas A, McDonald SA, Vohr BR, Hintz SR, Yolton K, et al. Childhood outcomes after hypothermia for neonatal encephalopathy. N Engl J Med 2012; 366: 2085-2092.##13.	Ristovska S, Stomnaroska O, Danilovski D. Hypoxic ischemic encephalopathy (HIE) in term and preterm infants. Pril 2022; 43: 77-84.##14.	Guillet R, Edwards AD, Thoresen M, Ferriero DM, Gluckman PD, Whitelaw A, et al. Seven- to eight-year follow-up of the CoolCap trial of head cooling for neonatal encephalopathy. Pediatr Res 2012; 71: 205-209.##15.	Preeti S, Kadam A, Kadam S, Vaidya U, Kumar P, Bhagat I, et al. Anthropometric measures as biomarkers of neurodevelopmental outcomes of newborns with moderate to severe hypoxic ischemic encephalopathy. J Neonatal Perinatal Med 2019; 12: 127-134.##16.	Murden S, Borbélyová V, Laštůvka Z, Mysliveček J, Otáhal J, Riljak V. Gender differences involved in the pathophysiology of the perinatal hypoxic-ischemic damage. Physiol Res 2019; 68 (Suppl.): S207-S217.##17.	Russ JB, Simmons R, Glass HC. Neonatal encephalopathy: Beyond hypoxic-ischemic encephalopathy. Neoreviews 2021; 22: e148-e162.##18.	Kwon JM, Guillet R, Shankaran S, Laptook AR, McDonald SA, Ehrenkranz RA, et al. Clinical seizures in neonatal hypoxic-ischemic encephalopathy have no independent impact on neurodevelopmental outcome: Secondary analyses of data from the neonatal research network hypothermia trial. J Child Neurol 2011; 26: 322-328.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Intrauterine autologous platelet-rich plasma treatment in women with at least two implantation failures: A retrospective cohort study</TitleF>
		<TitleE>درمان پلاسمای غنی از پلاکت اتولوگ داخل رحمی در زنان با حداقل دو شکست لانه-گزینی: یک مطالعه کوهورت گذشته نگر</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: یافتن مؤثرترین راه برای بهبود میزان لانه&#173;گزینی در زنانی که تحت درمان با تکنولوژی کمک باروری هستند هنوز یک چالش است.
هدف: این مطالعه با هدف ارزیابی پیامدهای حاملگی درمان با پلاسمای غنی از پلاکت داخل رحمی (PRP) در زنان با سابقه حداقل دو شکست لانه&#173;گزینی انجام شد.
مواد و روش&#173; ها: در این مطالعه کوهورت گذشته&#8204;نگر، داده&#8204;های 852 زن کاندید انتقال جنین منجمد-ذوب شده از فروردین 1396 تا شهریور 1400 در پژوهشکده علوم تولید&#173;مثل یزد ایران استخراج شد. از این تعداد، 432 مورد درمان PRP داخل رحمی 48 ساعت قبل از انتقال دریافت کردند (گروه PRP) و نتایج بارداری با 420 نفر (گروه کنترل) که درمان را قبل از انتقال دریافت نکردند مقایسه شد.
نتایج: پیامدهای حاملگی شامل میزان حاملگی شیمیایی،کلینیکی، بارداری در حال پیشرفت و تولد زنده در گروه PRP از نظر آماری تفاوت معنی&#8204;دار داشت (001/0 &#62; p). اگرچه هنگامی که بر اساس تاریخچه تعداد موارد شکست لانه&#173;گزینی طبقه&#173;بندی انجام شد، این بهبود قابل توجه در هر چهار مورد تنها در زنان با سابقه&#173;ی حداقل دو شکست لانه&#173;گزینی دیده شد. در زنان با سابقه تنها یک شکست لانه&#173;گزینی، درمان با پی&#173;آر&#173;پی به طور قابل توجهی باعث بهبود حاملگی در حال پیشرفت و میزان تولد زنده شد (5/19%، 04/0 = p). همچنین، در زنانی که تخمک اهدایی دریافت کردند و شکست لانه&#173;گزینی مکرر داشتند، PRP باعث بهبود بارداری شد. اما از نظر آماری معنی&#173;دار نبود (15/0 = p).
نتیجه&#173; گیری: به نظر می&#8204;رسد PRP در بهبود میزان بارداری در زنان با سابقه 2 یا بیشتر شکست لانه&#8204;گزینی مؤثر بوده و همچنین افزایش نرخ تولد زنده را در بیمارانی که تنها یک بار لانه&#8204;گزینی ناموفق داشتند نشان می&#8204;دهد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Finding the most effective way to improve implantation rate in women who are receiving assisted reproductive technology treatment is still a challenge.
Objective: This study aimed to assess the pregnancy outcomes of intrauterine platelet-rich plasma (PRP) therapy in women with a history of at least 2 implantation failures.
Materials and Methods: In this retrospective cohort study, data of 852 women who were candidates for frozen-thawed embryo transfer was extracted from their medical records from April 2017 to September 2021 at Yazd Reproductive Sciences Institute, Yazd, Iran. Of these, 432 received intrauterine PRP treatment 48 hr before transfer (PRP group), and the results of the pregnancy outcomes compared with 420 of the control group who did not receive the treatment before transfer.
Results: Pregnancy outcomes, including chemical, clinical, ongoing pregnancy, and live birth rate were statistically significant in the PRP group (p &#60; 0.001). However, when categorized according to the implantation history, this significant improvement in all 4 was only seen in women with at least 2 prior implantation failures. In women with a history of only one implantation failure, PRP therapy significantly improved the ongoing pregnancy and live birth rate (19.5%, p = 0.04). Also, in women who received donor eggs and had repeated implantation failure, PRP improved pregnancy outcomes clinically but not statistically (p = 0.15).
Conclusion: PRP seems to be effective in improving the pregnancy rate in women with a history of 2 or more implantation failures and also shows an increase in the live birth rate in women with only one implantation failure.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>9</FPAGE>
			<TPAGE>16</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2023/06/262023/10/24
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1402/8/2
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2023/12/252023/12/19
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1402/9/28
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Neda</Name>
				<MidName></MidName>
				<Family>Fattahi Meybodi</Family>
				<NameE>Neda</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Fattahi Meybodi</FamilyE>
				<Organizations>
				<Organization>Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>nedafatahi@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Maryam</Name>
				<MidName></MidName>
				<Family>Eftekhar</Family>
				<NameE>Maryam</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Eftekhar</FamilyE>
				<Organizations>
				<Organization>Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>eftekharmaryam@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Behnaz</Name>
				<MidName></MidName>
				<Family>Gandom</Family>
				<NameE>Behnaz</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Gandom</FamilyE>
				<Organizations>
				<Organization>Research and Clinical Center for Infertility, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>behnaz.gandom@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Platelet-rich plasma</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Embryo implantation</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Assisted reproductive technology</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Ovum donor</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Live birth rate.</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>پلاسمای غنی از پلاکت</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>شکست لانه‌گزینی جنین</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>فناوری کمک باروری</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>اهداکننده تخمک</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>میزان تولد زنده.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Nazari L, Salehpour S, Hoseini S, Zadehmodarres Sh, Ajori L. Effects of autologous platelet-rich plasma on implantation and pregnancy in repeated implantation failure: A pilot study. Int J Reprod BioMed 2016; 14: 625-628.##2.	Kasius A, Smit JG, Torrance HL, Eijkemans MJ, Mol BW, Opmeer BC, et al. Endometrial thickness and pregnancy rates after IVF: A systematic review and meta-analysis. Hum Reprod Update 2014; 20: 530-541.##3.	Aghajanova L, Houshdaran S, Balayan S, Irwin J, Huddleston H, Giudice L. Platelets for endometrial regeneration: A novel approach. Fertil Steril 2016; 106: e82.##4.	Arefi S, Fazeli E, Esfahani M, Borhani N, Yamini N, Hosseini A, et al. Granulocyte-colony stimulating factor may improve pregnancy outcome in patients with history of unexplained recurrent implantation failure: An RCT. Int J Reprod BioMed 2018; 16: 299-304.##5.	Barad DH, Yu Y, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee H-J, et al. A randomized clinical trial of endometrial perfusion with granulocyte colony-stimulating factor in in vitro fertilization cycles: Impact on endometrial thickness and clinical pregnancy rates. Fertil Steril 2014; 101: 710-715.##6.	Bos-Mikich A, Ferreira MO, de Oliveira R, Frantz N. Platelet-rich plasma or blood-derived products to improve endometrial receptivity? J Assist Reprod Genet 2019; 36: 613-620.##7.	Hviid MM, Macklon N. Immune modulation treatments-where is the evidence? Fertil Steril 2017; 107: 1284-1293.##8.	Jain S, Mahey R, Malhotra N, Kalaivani M, Sangeeta P, Bhatt A, et al. Effect of intrauterine perfusion of granulocyte colony-stimulating factor on endometrial parameters and in vitro fertilization outcome in women undergoing in vitro fertilization/intracytoplasmic sperm injection cycles: A randomized controlled trial. J Hum Reprod Sci 2018; 11: 254-260.##9.	Tandulwadkar SR, Naralkar MV, Surana AD, Selvakarthick M, Kharat AH. Autologous intrauterine platelet-rich plasma instillation for suboptimal endometrium in frozen embryo transfer cycles: A pilot study. J Hum Reprod Sci 2017; 10: 208-212.##10.	Davari-Tanha F, Tehraninejad ES, Ghazi M, Shahraki Z. The role of G-CSF in recurrent implantation failure: A randomized double blind placebo control trial. Int J Reprod BioMed 2016; 14: 737-742.##11.	Huang C, Ye X, Ye L, Lu L, Liu F. Platelet-rich plasma intrauterine infusion as assisted reproduction technology (ART) to combat repeated implantation failure (RIF): A systematic review and meta-analysis. Iran J Public Health 2023; 52: 1542-1554.##12.	Welte K. G-CSF: Filgrastim, lenograstim and biosimilars. Expert Opin Biol Ther 2014; 14: 983-993.##13.	Zadehmodarres Sh, Salehpour S, Saharkhiz N, Nazari L. Treatment of thin endometrium with autologous platelet-rich plasma: A pilot study. JBRA Assist Reprod 2017; 21: 54-56.##14.	Eftekhar M, Neghab N, Khani P. Effectiveness of autologous platelet-rich plasma therapy in women with repeated implantation failure: An RCT. Int J Fertil Steril 2023; in Press.##15.	Eftekhar M, Neghab N, Naghshineh E, Khani P. Can autologous platelet rich plasma expand endometrial thickness and improve pregnancy rate during frozen-thawed embryo transfer cycle? A randomized clinical trial. Taiwan J Obstet Gynecol 2018; 57: 810-813.##16.	Tehraninejad ES, Kashani NG, Hosseini A, Tarafdari A. Autologous platelet‐rich plasma infusion does not improve pregnancy outcomes in frozen embryo transfer cycles in women with history of repeated implantation failure without thin endometrium. J Obstet Gynaecol Res 2021; 47: 147-151.##17.	Ban Y, Yang X, Xing Y, Que W, Yu Z, Gui W, et al. Intrauterine infusion of leukocyte-poor platelet-rich plasma is an effective therapeutic protocol for patients with recurrent implantation failure: A retrospective cohort study. J Clin Med 2023; 12: 2823.##18.	Xu Y, Hao C, Fang J, Liu X, Xve P, Miao R. Intrauterine perfusion of autologous platelet-rich plasma before frozen-thawed embryo transfer improves the clinical pregnancy rate of women with recurrent implantation failure. Front Med 2022; 9: 64-67.##19.	Kong X, Tang G, Liu Y, Zheng Z, Li Y, Yan F. Efficacy of intrauterine infusion therapy before embryo transfer in recurrent implantation failure: A systematic review and network meta-analysis. J Reprod Immunol 2023; 156: 103819.##20.	Deng H, Wang S, Li Z, Xiao L, Ma L. Effect of intrauterine infusion of platelet-rich plasma for women with recurrent implantation failure: A systematic review and meta-analysis. J Obstet Gynaecol 2023; 43: 2144177.##21.	Kaur H, Meenu M, Pandey S, Chauhan A, Mangla M. Efficacy and safety of PRP in patients with recurrent implantation failure undergoing ART-A systematic review &#38; meta-analysis. Authorea Preprints; 2023.##22.	Abd Elsalam Elgendy HE, Mohamed SA. Efficacy of intra-uterine infusion of PRP for pregnancy related outcomes in women with recurrent implantation failure; systematic review and meta-analysis of published trials. Egypt J Fertil Steril 2023; 27: 18-26.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Sertoli cell-conditioned medium can improve blood-testis-barrier function and spermatogenesis in azoospermia mice induced by scrotal hyperthermia: An experimental study</TitleF>
		<TitleE>محیط کشت بهینه مشتق از سلول های سرتولی می تواند سبب بهبود عملکرد سد خونی-بیضه ای و اسپرماتوژنز در موش های مدل آزواسپرمی القا شده با هیپرترمی اسکروتال شود: یک مطالعه تجربی</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: افزایش دمای بیضه با آسیب به اپیتلیوم لوله&#173;های اسپرم&#173;ساز و اختلال در تولید اسپرم همراه است.
هدف: هدف از مطالعه کنونی بررسی اثرات محیط کشت بهینه مشتق از سلول&#173;های سرتولی (SCCM) بر ژن&#173;های مرتبط با سد خونی-بیضه&#173;ای و فرآیند اسپرماتوژنز به دنبال القای هایپرترمی اسکروتال بود.
مواد و روش&#173; ها: در این مطالعه 40 سر موش سوری نژاد NMRI بالغ 8 هفته با وزن 30-25 گرم به&#173;صورت تصادفی به 4 گروه تقسیم شدند: (I کنترل،&#160;&#160;&#160;&#160; &#160;DMEM (II، (III هایپرترمی اسکروتال، و IV) هایپرترمی اسکروتال+SCCM. هایپرترمی با قرار دادن ناحیه اسکروتال موش&#173;ها در آب 43 درجه سانتی&#173;گراد به مدت 20 دقیقه به صورت یک روز در میان و به مدت 10 روز القا گردید. موش&#173;ها در گروه II و IV به مدت 5 هفته و به صورت یک روز درمیان به ترتیب&#160; &#160;(&#956;l 10) DMEM F/12 و (&#956;l 10) SCCM دریافت کردند. سپس موش&#173;ها قربانی شده و دم اپی-دیدیم آن&#173;ها جهت بررسی پارامترهای اسپرم، بیضه&#173;ها جهت مطالعات استریولوژیکال، سطح ROS و GSH، و بیان ژن&#173;های Ocln, Gja1, Cdh2 و Itgb1 جدا شدند.
نتایج: نتایج آنالیز اسپرم نشان داد که در موش&#173;های تحت درمان با SCCM به&#173;صورت معناداری تعداد و تحرک اسپرم&#173;ها افزایش و از هم&#173;گسیختگی DNA آن&#173;ها کاهش یافته بود. همچنین، یافته&#173;های بافتی و مولکولی نشان&#173;دهنده افزایش حجم بافت بیضه، شمار سلول&#173;های زایا، سطح GSH و بیان ژن&#173;های Ocln, Gja1, Cdh2 و Itgb1 در گروه تحت درمان با SCCM در مقایسه با گروه هایپرترمی اسکروتال بود.
نتیجه&#173; گیری: یافته&#8204;ها نشان می&#8204;دهد که فاکتورهای رشد SCCM تکثیر و تمایز سلول&#8204;های زایا را از طریق اثرات پاراکرین تحریک می&#8204;کنند و بیان ژن&#173;های مرتبط با سد خونی-بیضه&#173;ای را در موش&#173;های تحت القای هایپرترمی اسکروتال تنظیم می&#173;کنند.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: An increase in the temperature of the testis is associated with damage to the epithelium of seminiferous tubules and disruption of sperm production.
Objective: The current study aimed to investigate the effect of the Sertoli cell-conditioned medium (SCCM) on the blood-testis-barrier associated genes and spermatogenesis process following scrotal hyperthermia.
Materials and Methods: In this experimental study, 40 adult NMRI mice (8 wk, 25-30 gr) were allocated into 4 groups: I) control, II) DMEM (10 &#956;l Dulbecco&#39;s Modified Eagle Medium), III) scrotal hyperthermia, and IV) scrotal hyperthermia+SCCM (10 &#956;l SCCM). Hyperthermia was induced by placing the mice scrotum in water at 43&#176;C for 20 min every other day for 10 days. Mice were treated every other day for 5 wk. Then the animals were euthanized, and the tails of epididymis were removed to analyze sperm parameters, testis were taken for stereological assessment, reactive oxygen spices and glutathione levels, and the expression of Ocln, Gja1, Cdh2, and Itgb1.
Results: The results of sperm analysis indicated that SCCM-treated mice significantly increased sperm count and motility and reduced DNA fragmentation. In addition, histological and molecular findings showed that the volume of testicular tissue, the number of germ cells, the glutathione level, and the expression of Ocln, Gja1, Cdh2, and Itgb1 genes were significantly increased in the SCCM-treated mice.
Conclusion: Findings suggest that growth factors of SCCM stimulate the proliferation and differentiation of germ cells through paracrine effects and upregulate the blood-testis-barrier-associated genes in mice subjected to scrotal hyperthermia.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>17</FPAGE>
			<TPAGE>30</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2023/06/262023/10/242023/10/26
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1402/8/4
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2023/12/252023/12/192024/01/8
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1402/10/18
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Fakhroddin</Name>
				<MidName></MidName>
				<Family>Aghajanpour</Family>
				<NameE>Fakhroddin</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Aghajanpour</FamilyE>
				<Organizations>
				<Organization>Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.  Student Research Committee, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>fakhroddin72@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Reza</Name>
				<MidName></MidName>
				<Family>Soltani</Family>
				<NameE>Reza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Soltani</FamilyE>
				<Organizations>
				<Organization>Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.  Student Research Committee, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>rezasoltanikazemii@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Azar</Name>
				<MidName></MidName>
				<Family>Afshar</Family>
				<NameE>Azar</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Afshar</FamilyE>
				<Organizations>
				<Organization>Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.  Student Research Committee, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>azar.afshar8894@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Hojjat-Allah</Name>
				<MidName></MidName>
				<Family>Abbaszadeh</Family>
				<NameE>Hojjat-Allah</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Abbaszadeh</FamilyE>
				<Organizations>
				<Organization>Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>hoomanabs@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Fatemeh</Name>
				<MidName></MidName>
				<Family>Fadaei Fathabadi</Family>
				<NameE>Fatemeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Fadaei Fathabadi</FamilyE>
				<Organizations>
				<Organization>Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>fatemeh.fadaeifathabadi@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Nafiseh</Name>
				<MidName></MidName>
				<Family>Moeinian</Family>
				<NameE>Nafiseh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Moeinian</FamilyE>
				<Organizations>
				<Organization>Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>moeinian.ptu@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Abbas</Name>
				<MidName></MidName>
				<Family>Aliaghaei</Family>
				<NameE>Abbas</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Aliaghaei</FamilyE>
				<Organizations>
				<Organization>Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>aghaei60@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Ali</Name>
				<MidName></MidName>
				<Family>Dehghani Nejad</Family>
				<NameE>Ali</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Dehghani Nejad</FamilyE>
				<Organizations>
				<Organization>Department of Biology and Anatomical Sciences, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>amirali3532@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Reza</Name>
				<MidName></MidName>
				<Family>Mastery Farahani</Family>
				<NameE>Reza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Mastery Farahani</FamilyE>
				<Organizations>
				<Organization>Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>realmastery@hotmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mohsen</Name>
				<MidName></MidName>
				<Family>Norouzian</Family>
				<NameE>Mohsen</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Norouzian</FamilyE>
				<Organizations>
				<Organization>Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>norozian93@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mohammad-Amin</Name>
				<MidName></MidName>
				<Family>Abdollahifar</Family>
				<NameE>Mohammad-Amin</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Abdollahifar</FamilyE>
				<Organizations>
				<Organization>Department of Biology and Anatomical Sciences, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>m_amin58@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Testis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Sertoli cells</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Culture media</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Hyperthermia</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Spermatogenesis.</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>بیضه</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سلول سرتولی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>محیط کشت</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>هیپرترمی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>اسپرماتوژنز.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	McGregor GR, Vanos JK. Heat: A primer for public health researchers. Public Health 2018; 161: 138-146.##2.	Kastelic JP, Rizzoto GJBr. Thermoregulation of the testes. In: Hopper RM. Bovine reproduction. 2th Ed. US: John Wiley &#38; Sons; 2021. ##3.	Abd El-Emam MM, Ray MN, Ozono M, Kogure K. Heat stress disrupts spermatogenesis via modulation of sperm-specific calcium channels in rats. J Therm Biol 2023; 112: 103465.##4.	Durairajanayagam D, Agarwal A, Ong C. Causes, effects and molecular mechanisms of testicular heat stress. Reprod Biomed Online 2015; 30: 14-27.##5.	Mäkelä J-A, Koskenniemi JJ, Virtanen HE, Toppari J. Testis development. Endocr Rev 2019; 40: 857-905.##6.	O’Donnell L, Smith LB, Rebourcet D. Sertoli cells as key drivers of testis function. Semin Cell Dev Biol 2022; 121: 2-9.##7.	Arisha AH, Ahmed MM, Kamel MA, Attia YA, Hussein MMA. Morin ameliorates the testicular apoptosis, oxidative stress, and impact on blood–testis barrier induced by photo-extracellularly synthesized silver nanoparticles. Environ Sci Pollut Res Int 2019; 26: 28749-28762.##8.	Hu Y, Hu H, Yin L, Wang L, Luo K, Luo N, et al. Arachidonic acid impairs the function of the blood-testis barrier via triggering mitochondrial complex-ROS-P38 MAPK axis in hyperthermal Sertoli cells. Ecotoxicol Environ Saf 2023; 252: 114598.##9.	Mruk DD, Cheng CY. The mammalian blood-testis barrier: Its biology and regulation. Endocr Rev 2015; 36: 564-591.##10.	Chen S-R, Liu Y-X. Regulation of spermatogonial stem cell self-renewal and spermatocyte meiosis by Sertoli cell signaling. Reproduction 2015; 149: R159-R167.##11.	Hai Y, Hou J, Liu Y, Liu Y, Yang H, Li Z, et al. The roles and regulation of Sertoli cells in fate determinations of spermatogonial stem cells and spermatogenesis. Semin Cell Dev Biol 2014; 29: 66-75.##12.	Hajian Monfared M, Minaee B, Rastegar T, Khrazinejad E, Barbarestani M. Sertoli cell condition medium can induce germ like cells from bone marrow derived mesenchymal stem cells. Iran J Basic Med Sci 2016; 19: 1186-1192.##13.	Panahi S, Karamian A, Sajadi E, Aliaghaei A, Nazarian H, Abdi Sh, et al. Sertoli cell-conditioned medium restores spermatogenesis in azoospermic mouse testis. Cell Tissue Res 2020; 379: 577-587.##14.	Afshar A, Aliaghaei A, Nazarian H, Abbaszadeh H-A, Naserzadeh P, Fathabadi FF, et al. Curcumin-loaded iron particle improvement of spermatogenesis in azoospermic mouse induced by long-term scrotal hyperthermia. Reprod Sci 2021; 28: 371-380.##15.	Ziaeipour S, Piryaei A, Aliaghaei A, Nazarian H, Naserzadeh P, Ebrahimi V, et al. Chronic scrotal hyperthermia induces azoospermia and severe damage to testicular tissue in mice. Acta Histochem 2021; 123: 151712.##16.	Ayoubi M, Naserzadeh P, Hashemi MT, Rostami MR, Tamjid E, Tavakoli MM, et al. Biochemical mechanisms of dose-dependent cytotoxicity and ROS-mediated apoptosis induced by lead sulfide/graphene oxide quantum dots for potential bioimaging applications. Sci Rep 2017; 7: 12896.##17.	Oliveira PF, Alves MG. Sertoli cell metabolism and spermatogenesis. Cham: Springer; 2015: 25-39. ##18.	Parekh PA, Garcia TX, Hofmann M-C. Regulation of GDNF expression in Sertoli cells. Reproduction 2019; 157: R95-R107.##19.	Peng YJ, Tang XT, Shu HS, Dong W, Shao H, Zhou BO. Sertoli cells are the source of stem cell factor for spermatogenesis. Development 2023; 150: dev200706.##20.	Meroni SB, Galardo MN, Rindone G, Gorga A, Riera MF, Cigorraga SB. Molecular mechanisms and signaling pathways involved in sertoli cell proliferation. Front Endocrinol 2019; 10: 224.##21.	Muratori M, Tamburrino L, Marchiani S, Cambi M, Olivito B, Azzari C, et al. Investigation on the origin of sperm DNA fragmentation: Role of apoptosis, immaturity and oxidative stress. Mol Med 2015; 21: 109-122.##22.	Fu L, Yuen KCJ, Tint AN, Hoffman AR, Bongso AT, Lee KO. Association of decreased sperm motility and increased seminal plasma IGF-I, IGF-II, IGFBP-2, and PSA levels in infertile men. Endocrine 2021; 74: 698-706.##23.	Ghafouri-Fard S, Shoorei H, Mohaqiq M, Raza SHA, Taheri M. The role of different compounds on the integrity of blood-testis barrier: A concise review based on in vitro and in vivo studies. Gene 2021; 780: 145531.##24.	Su L, Wang Z, Xie S, Hu D, Cheng YC, Mruk DD, et al. Testin regulates the blood‐testis barrier via disturbing occludin/ZO‐1 association and actin organization. J Cell Physiol 2020; 235: 6127-6138.##25.	Piprek RP, Kloc M, Mizia P, Kubiak JZ. The central role of cadherins in gonad development, reproduction, and fertility. Int J Mol Sci 2020; 21: 8264.##26.	Zhang DC, Chen R, Cai YH, Wang JJ, Yin C, Zou K. Hyperactive reactive oxygen species impair function of porcine Sertoli cells via suppression of surface protein ITGB1 and connexin-43. Zool Res 2020; 41: 203-207.##27.	Yang W-R, Li B-B, Hu Y, Zhang L, Wang X-Z. Oxidative stress mediates heat-induced changes of tight junction proteins in porcine sertoli cells via inhibiting CaMKKβ-AMPK pathway. Theriogenology 2020; 142: 104-113.##28.	Hofmann M-C, McBeath E. Sertoli cell-germ cell interactions within the niche: Paracrine and juxtacrine molecular communications. Front Endocrinol 2022; 13: 897062.##29.	Lv D, Zhao M, Ni J, Liu W, Ren Y, Zhu D, et al. NGF regulates sertoli cell growth and prevents LPS-induced junction protein damage via PI3K/AKT/NFκB signaling. Theriogenology 2023; 195: 138-148.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Modulating the RFamide-related peptide-3/G protein-coupled receptor 147 signaling pathway with nourishing Yin-removing fire herbal mixture to alleviate precocious puberty in female rats: An experimental study</TitleF>
		<TitleE>تعدیل مسیر سیگنال دهی گیرنده 147 متصل به پروتئین پپتید-3/G مرتبط با RFamide با تجویز مخلوط گیاهی Yin-removing fire برای کاهش بلوغ زودرس موش های صحرایی ماده: یک مطالعه تجربی</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: بلوغ زودرس (PP) شامل فعال شدن زودهنگام مولد هورمون آزاد&#173;کننده گنادوتروپین هیپوتالاموس (GnRH) است. مسیر سیگنال&#173;دهی گیرنده 147 متصل به پروتئین پپتید-3/G مرتبط با RFamide (RFRP3/GPR147) در مهار GnRH و به تأخیر انداختن شروع بلوغ حیاتی است. مخلوط گیاهی&#160; &#160;Yin-removing fire (NYRF) نتایج امیدوارکننده&#173;ای را در درمان PP نشان داده است.
هدف: این مطالعه با هدف ارزیابی تأثیر مخلوط گیاهی NYRF بر مسیر سیگنالینگ RFRP3/GPR147 در هیپوتالاموس و توانایی آن در کاهش PP در موش&#8204;های ماده انجام شد.
مواد و روش&#173; ها: در یک آزمایش کنترل &#8204;شده، 24 موش صحرایی ماده نژاد Sprague-Dawley (69/0 &#177; 20/11 گرم، 5 روز پس از زایمان [PD5]) به گروه&#8204;های نرمال، مدل، نرمال سالین و NYRF (هر کدام 6 رأس) تقسیم شدند. PP در گروه&#173;های مدل، نرمال سالین و NYRF با تزریق زیر جلدی دانازول در PD5 القا شد. مخلوط گیاهی NYRF یا نرمال سالین از PD15 تجویز شد. سطح سرمی هورمون&#173;های جنسی و نمونه&#173;های هیپوتالاموس برای بررسی بیان mRNA و پروتئین در PD30 جمع&#173;آوری شد.
نتایج: در گروه مدل، سطوح GnRH هیپوتالاموس و کیسپپتین افزایش یافت، در حالی که سطوح RFRP3 و GPR147 کاهش یافت، سطح هورمون&#160;&#160; &#160;لوتئینه&#173;کننده افزایش یافت، ضرایب اندام تناسلی افزایش یافت و واژن نسبت به گروه عادی زودتر باز شد. در حالیکه برعکس، گروه NYRF سطوح GnRH و کیسپپتین کمتر اما سطوح RFRP3 بالاتری را در هیپوتالاموس نشان دادند. همچنین در این گروه سطح هورمون لوتئینیزه&#173;کننده سرم کاهش یافت، ضرایب اندام تناسلی کاهش یافت و باز شدن واژن در مقایسه با مدل و گروه نرمال سالین به تعویق افتاد.
نتیجه&#173; گیری: مخلوط گیاهی NYRF رشد جنسی در موش&#8204;های مبتلا به PP را با افزایش RFRP3 هیپوتالاموس و کاهش GnRH و کیسپپتین به تأخیر انداخت.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Precocious puberty (PP) involves early activation of the hypothalamic gonadotropin-releasing hormone (GnRH) generator. The RFamide-related peptide/G protein-coupled receptor 147 (RFRP3/GPR147) signaling pathway is vital in inhibiting GnRH and delaying puberty onset. The nourishing Yin-removing fire (NYRF) herbal mixture has shown promising results in treating PP.
Objective: This study aimed to assess the impact of the NYRF herbal mixture on the RFRP3/GPR147 signaling pathway in the hypothalamus and its potential in alleviating PP in female rats.
Materials and Methods: In a controlled experiment, 24 female Sprague-Dawley rats (11.20 &#177; 0.69 gr, postnatal day [PD5]) were divided into normal, model, normal saline, and NYRF groups (n = 6/each). PP was induced in the model, normal saline, and NYRF groups by subcutaneous injection of danazol at PD5. The NYRF herbal mixture or normal saline was administered from PD15. Serum sex hormone levels and hypothalamic samples were collected for mRNA and protein expression at PD30.
Results: In the model group, hypothalamic GnRH and kisspeptin levels increased, while RFRP3 and GPR147 levels decreased, luteinizing hormone levels elevated, reproductive organ coefficients increased, and the vagina opened earlier compared to the normal group. Conversely, the NYRF group exhibited lower GnRH and kisspeptin levels but higher RFRP3 levels in the hypothalamus. Serum luteinizing hormone levels were reduced, reproductive organ coefficients were reduced, and the vaginal opening was delayed compared to the model and normal saline groups.
Conclusion: The NYRF herbal mixture delayed sexual development in rats with PP by hypothalamic upregulating RFRP3 and downregulating GnRH and kisspeptin.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>31</FPAGE>
			<TPAGE>42</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2023/06/262023/10/242023/10/262023/07/2
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1402/4/11
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2023/12/252023/12/192024/01/82024/01/13
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1402/10/23
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Xiaoli</Name>
				<MidName></MidName>
				<Family>Dai</Family>
				<NameE>Xiaoli</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Dai</FamilyE>
				<Organizations>
				<Organization>Traditional Chinese Medicine Department, Children's Hospital of Fudan University, Shanghai, China.</Organization>
				</Organizations>
				<Countries>
				<Country>چین</Country>
				</Countries>
				<EMAILS>
				<Email>yezi_i@163.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Yuanyuan</Name>
				<MidName></MidName>
				<Family>He</Family>
				<NameE>Yuanyuan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>He</FamilyE>
				<Organizations>
				<Organization>Traditional Chinese Medicine Department, Children's Hospital of Fudan University, Shanghai, China.</Organization>
				</Organizations>
				<Countries>
				<Country>چین</Country>
				</Countries>
				<EMAILS>
				<Email>yuanyuan_he@qq.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Suhuan</Name>
				<MidName></MidName>
				<Family>Li</Family>
				<NameE>Suhuan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Li</FamilyE>
				<Organizations>
				<Organization>Yantaishan Hospital, Shangdong, China.</Organization>
				</Organizations>
				<Countries>
				<Country>چین</Country>
				</Countries>
				<EMAILS>
				<Email>lisuhuan1987@qq.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Yanyan</Name>
				<MidName></MidName>
				<Family>Sun</Family>
				<NameE>Yanyan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Sun</FamilyE>
				<Organizations>
				<Organization>Traditional Chinese Medicine Department, Children's Hospital of Fudan University, Shanghai, China.</Organization>
				</Organizations>
				<Countries>
				<Country>چین</Country>
				</Countries>
				<EMAILS>
				<Email>sunyanyan09@fudan.edu.cn</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Wen</Name>
				<MidName></MidName>
				<Family>Sun</Family>
				<NameE>Wen</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Sun</FamilyE>
				<Organizations>
				<Organization>Traditional Chinese Medicine Department, Children's Hospital of Fudan University, Shanghai, China.</Organization>
				</Organizations>
				<Countries>
				<Country>چین</Country>
				</Countries>
				<EMAILS>
				<Email>sunwenhere@163.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Zhanzhuang</Name>
				<MidName></MidName>
				<Family>Tian</Family>
				<NameE>Zhanzhuang</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Tian</FamilyE>
				<Organizations>
				<Organization>Department of Integrative Medicine and Neurobiology, Fudan University, Shanghai, China.</Organization>
				</Organizations>
				<Countries>
				<Country>چین</Country>
				</Countries>
				<EMAILS>
				<Email>tianvv@shum.edu.cn</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Jian</Name>
				<MidName></MidName>
				<Family>Yu</Family>
				<NameE>Jian</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Yu</FamilyE>
				<Organizations>
				<Organization>Traditional Chinese Medicine Department, Children's Hospital of Fudan University, Shanghai, China.</Organization>
				</Organizations>
				<Countries>
				<Country>چین</Country>
				</Countries>
				<EMAILS>
				<Email>yuj@shmu.edu.cn</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Nurgul Yerkinkyzy</Name>
				<MidName></MidName>
				<Family>Ablakimova</Family>
				<NameE>Nurgul Yerkinkyzy</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ablakimova</FamilyE>
				<Organizations>
				<Organization>Department of Pharmacology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan.</Organization>
				</Organizations>
				<Countries>
				<Country>چین</Country>
				</Countries>
				<EMAILS>
				<Email>n.ablakimova@zkmu.kz</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Yonghong</Name>
				<MidName></MidName>
				<Family>Wang</Family>
				<NameE>Yonghong</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Wang</FamilyE>
				<Organizations>
				<Organization>Traditional Chinese Medicine Department, Children's Hospital of Fudan University, Shanghai, China.</Organization>
				</Organizations>
				<Countries>
				<Country>چین</Country>
				</Countries>
				<EMAILS>
				<Email>wyhekyy@126.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Nourishing Yin-removing fire</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>RFamide-related peptide-3</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>G protein-coupled receptor 147</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Hypo-thalamus</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Puberty</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Precocious.</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>مخلوط گیاهی Yin-removing fire</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>پپتید-3 مرتبط با RFamide</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>گیرنده 147 متصل به پروتئین G</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>هیپوتالاموس</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>بلوغ</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>زودرس.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Bradley SH, Lawrence N, Steele C, Mohamed Z. Precocious puberty. BMJ 2020; 368: l6597. ##2.	Liu Y, Yu T, Li X, Pan D, Lai X, Chen Y, et al. Prevalence of precocious puberty among Chi-nese children: A school population-based study. Endocrine 2021; 72: 573-581. ##3.	Naulé L, Maione L, Kaiser UB. Puberty, a sensitive window of hypothalamic development and plasticity. Endocrinology 2021; 162: bqaa209. ##4.	Plant TM, Steiner RA. The fifty years following the discovery of gonadotropin‐releasing hor-mone. J Neuroendocrinol 2022; 34: e13141. ##5.	Xie Q, Kang Y, Zhang C, Xie Y, Wang C, Liu J, et al. The role of kisspeptin in the control of the hypothalamic-pituitary-gonadal axis and reproduction. Front Endocrinol 2022; 13: 925206. ##6.	Singh P, Anjum S, Srivastava RK, Tsutsui K, Krishna A. Central and peripheral neuropeptide RFRP-3: A bridge linking reproduction, nutrition, and stress response. Front Neuroendocrinol 2022; 65: 100979. ##7.	Tsutsui K, Ubuka T. Discovery of gonadotropin-inhibitory hormone (GnIH), progress in GnIH research on reproductive physiology and behavior and perspective of GnIH research on neuro-endocrine regulation of reproduction. Mol Cell Endocrinol 2020; 514: 110914. ##8.	Tsutsui K, Ubuka T. Gonadotropin-inhibitory hormone (GnIH): A new key neurohormone con-trolling reproductive physiology and behavior. Front Neuroendocrinol 2021; 61: 100900. ##9.	Wang H, Khoradmehr A, Jalali M, Salehi MS, Tsutsui K, Jafarzadeh Shirazi MR, et al. The roles of RFamide-related peptides (RFRPs), mammalian gonadotropin-inhibitory hormone (GnIH) orthologues in female reproduction. Iran J Basic Med Sci 2018; 21: 1210-1220. ##10.	Mohapatra SS, Mukherjee J, Banerjee D, Das PK, Ghosh PR, Das K. RFamide peptides, the novel regulators of mammalian HPG axis: A review. Vet World 2021; 14: 1867-1873. ##11.	Han X, He Y, Zeng G, Wang Y, Sun W, Liu J, et al. Intracerebroventricular injection of RFRP-3 delays puberty onset and stimulates growth hormone secretion in female rats. Reprod Biol Endo-crinol 2017; 15: 35. ##12.	Yu C-H, Liu P-H, Van Y-H, Lien AS-Y, Huang T-P, Yen H-R. Traditional Chinese medicine for idiopathic precocious puberty: A hospital-based retrospective observational study. Complement Ther Med 2014; 22: 258-265. ##13.	Sun W, Han X, Wang Y, Yu J, Yan W, Zhao J, et al. Effectiveness of Ziyin Xiehuo granules and Zishen Qinggan granules on partial precocious puberty in girls: A multicenter, randomized, sin-gle-blind, controlled trial. J Tradit Chin Med 2018; 38: 740-745. ##14.	Huang R, Zeng G-Z, Huang H-Y, Wang Y-H, Yu J. [Further exploration on the essence of yin deficiency caused fire hyperactivity syndrome in precocious puberty children patients]. Zhongguo Zhong Xi Yi Jie He Za Zhi 2016; 36: 879-881. (In Chinese)##15.	Zeng G, Han X, Yu J, Wang Y, Tian Z. Effect of nourishing &#34;yin&#34; removing &#34;fire&#34; chinese herbal mixture on hypothalamic mammalian target of rapamycin expression during onset of puberty in female rats. Evid Based Complement Alternat Med 2015; 2015: 157846. ##16.	He Y, Han X, Sun W, Yu J, Tamadon A. Precocious puberty and the Lin28/Let7 pathway: The therapeutic effect of the nourishing &#34;Yin&#34; and purging &#34;Fire&#34; traditional chinese medicine mixture in a rat model. Evid Based Complement Alternat Med 2018; 2018: 4868045.##17.	Wang S, Zhu L, Yu J, Tian Z. Effect of nourishing “Yin”-removing “Fire” Chinese herbal mix-ture on hypothalamic NKB/NK3R expression in female precocious rats. Evid Based Complement Alternat Med 2014; 2014: 217424. ##18.	Bai G-L, Hu K-L, Huan Y, Wang X, Lei L, Zhang M, et al. The traditional chinese medicine fuyou formula alleviates precocious puberty by inhibiting GPR54/GnRH in the hypothalamus. Front Pharmacol 2021; 11: 596525. ##19.	Auta T, Hassan AT. Alteration in oestrus cycle and implantation in Mus musculus administered aqueous wood ash extract of Azadirachta indica (neem). Asian Pac J Reprod 2016; 5: 188-192.##20.	Laferriere CA, Pang DS. Review of intraperitoneal injection of sodium pentobarbital as a method of euthanasia in laboratory rodents. J Am Assoc Lab Anim Sci 2020; 59: 254-263.##21.	Guarneri AM, Kamboj MK. Physiology of pubertal development in females. Pediatr Med 2019; 2: 42-49. ##22.	Wahab F, Atika B, Ullah F, Shahab M, Behr R. Metabolic impact on the hypothalamic kisspep-tin-Kiss1r signaling pathway. Front Endocrinol 2018; 9: 123.##23.	Han X-X, Zhao F-Y, Gu K-R, Wang G-P, Zhang J, Tao R, et al. Development of precocious pu-berty in children: Surmised medicinal plant treatment. Biomed Pharmacother 2022; 156: 113907. ##24.	Livadas S, Chrousos GP. Control of the onset of puberty. Curr Opin Pediatr 2016; 28: 551-558. ##25.	Tsutsui K, Ubuka T, Ukena K. Advancing reproductive neuroendocrinology through research on the regulation of GnIH and on its diverse actions on reproductive physiology and behavior. Front Neuroendocrinol 2022; 64: 100955. ##26.	Sun W, Li S, Tian Zh, Shi Y, Yu J, Sun Y, et al. Dynamic changes of RFRP3/GPR147 in the precocious puberty model female rats. Curr Mol Med 2019; 19: 766-775. ##27.	Uenoyama Y, Inoue N, Nakamura S, Tsukamura H. Kisspeptin neurons and estrogen–estrogen receptor α signaling: Unraveling the mystery of steroid feedback system regulating mammalian reproduction. Int J Mol Sci 2021; 22: 9229. ##28.	Maione L, Bouvattier C, Kaiser UB. Central precocious puberty: Recent advances in under-standing the aetiology and in the clinical approach. Clin Endocrinol 2021; 95: 542-555. ##29.	Stein AD, Lundeen EA, Martorell R, Suchdev PS, Mehta NK, Richter LM, et al. Pubertal de-velopment and prepubertal height and weight jointly predict young adult height and body mass index in a prospective study in South Africa. J Nutr 2016; 146: 1394-1401.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Chronic demyelination interferes with normal spermatogenesis in cuprizone-intoxicant C57/BL 6 mice: An experimental study</TitleF>
		<TitleE>دمیلیناسیون مزمن در روند اسپرماتوژنز طبیعی موش ای C57/BL 6 سمی شده با کوپریزون تداخل ایجاد می‌کند: یک مطالعه تجربی</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: به دلیل آسیب&#173;های وارده به میلین و آکسون سلول&#173;های عصبی در افراد مبتلا به مولتیپل اسکلروزیس، ممکن است عدم هماهنگی حرکتی و عدم تعادل در ترشحات غدد درون&#173;ریز ایجاد گردد.
هدف: هدف این مطالعه، بررسی نقش دمیلیناسیون مزمن بر محور هیپوتالاموس-هیپوفیز-گناد در مدل موشی مولتیپل اسکلروزیس بوده است.
مواد و روش&#173; ها: 20 رأس موش C57/BL 6 بالغ نر به دو گروه (10 راس در هر گروه) به شرح ذیل تقسیم شدند: گروه کنترل که یک رژیم غذایی معمول را به مدت 17 هفته دریافت کردند (CONT)، گروه آزمایش (cuprizone [CPZ]) که ابتدا به مدت 12 هفته با غذای حاوی 2/0% سم کوپریزون تغذیه شدند ولی سپس به مدت 5 هفته سم کوپریزون از رژیم غذایی قطع گردید. سطح تستوسترون سرم، هیستوپاتولوژی بافت&#173;های مغز و بیضه، و همچنین پارامترهای اسپرم مورد ارزیابی قرار گرفت.
نتایج: محتوای میلین هسته قوسی هیپوتالاموس به طور قابل توجهی پس از 12 هفته مصرف سم کوپریزون در مقایسه با گروه CONT کاهش یافت و این تفاوت آماری تا 17 هفته باقی ماند. سطح تستوسترون به طور قابل توجهی در گروه CPZ در مقایسه با گروه CONT در هفته&#173;های 12 و 17 کاهش یافت. کاهش قابل توجهی در ارتفاع اپیتلیوم لوله&#173;های منی&#173;ساز و مساحت بافت بینابینی و همچنین تعداد انواع سلول&#173;های اپیتلیال لوله&#173;های منی&#173;ساز در گروه CPZ نسبت به گروه CONT، در هفته 12 و 17 مشاهده شد. تعداد اسپرم، تحرک و زنده&#173;مانی در گروه CPZ در مقایسه با گروه CONT در هفته 12 و 17 مطالعه به طور قابل توجهی کاهش یافت.
نتیجه&#173; گیری: دمیلیناسیون مزمن القا شده با سم کوپریزون، ممکن است از طریق آسیب&#173;رساندن به هسته قوسی هیپوتالاموس، منجر به اختلال در محور هیپوتالاموس- هیپوفیز- گناد و آسیب به بافت بیضه و متعاقباً تداخل در روند اسپرم&#8204;زایی گردد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Due to myelin and axonal insults in multiple sclerosis individuals, motor coordination problems and endocrine imbalance may develop. 
Objective: This study aims to evaluate the role of chronic demyelination on the hypothalamic-pituitary-gonadal axis in the mouse model of multiple sclerosis.
Materials and Methods: 20 adult C57/BL6 male mice were divided into 2 groups (n = 10/each) as follows: the control group (CONT) received a regular diet for 17 wk; and the experimental group (cuprizone [CPZ]) was fed with 0.2% CPZ for 12 wk and, then CPZ was withdrawn for 5 wk. Serum testosterone, histopathology of the brain and testis, and sperm analysis were evaluated.
Results: The hypothalamic myelin content was significantly decreased in the arcuate nucleus following the 12 wk of CPZ consumption compared to the CONT group, and the statistical difference remained until 17 wk. Testosterone levels declined significantly in the CPZ group compared to the CONT group in the 12th and 17th wk. A significant decrease was observed in the height of the seminiferous epithelium and the interstitial tissue area, and the number of seminiferous epithelial cells in the CPZ group compared to the CONT group in the 12th and 17th wk. The sperm count, motility, and viability in the CPZ group significantly decreased compared to the CONT group in the 12th and 17th wk of the study.
Conclusion: Chronic demyelination induced by CPZ intoxication, maybe through damage to the hypothalamus arcuate nucleus, leads to the hypothalamic-pituitary-gonadal axis disturbance and damage to the testis and spermatogenesis subsequently.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>43</FPAGE>
			<TPAGE>54</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2023/06/262023/10/242023/10/262023/07/22023/08/20
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1402/5/29
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2023/12/252023/12/192024/01/82024/01/132023/12/25
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1402/10/4
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Arezoo</Name>
				<MidName></MidName>
				<Family>Dorikhani</Family>
				<NameE>Arezoo</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Dorikhani</FamilyE>
				<Organizations>
				<Organization>Department of Anatomical Sciences, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>arezoo.d.73@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Ameneh</Name>
				<MidName></MidName>
				<Family>Omidi</Family>
				<NameE>Ameneh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Omidi</FamilyE>
				<Organizations>
				<Organization>Department of Anatomical Sciences, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>a.omidi@modares.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mansoureh</Name>
				<MidName></MidName>
				<Family>Movahedin</Family>
				<NameE>Mansoureh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Movahedin</FamilyE>
				<Organizations>
				<Organization>Department of Anatomical Sciences, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>movahed.m@modares.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Iman</Name>
				<MidName></MidName>
				<Family>Halvaei</Family>
				<NameE>Iman</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Halvaei</FamilyE>
				<Organizations>
				<Organization>Department of Anatomical Sciences, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>ihalvaei@modares.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Multiple sclerosis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Cuprizone</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Hypothalamic-pituitary-gonadal axis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Spermatogenesis.</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>مولتیپل اسکلروزیس</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>کوپریزون</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>محور هیپوتالاموس- هیپوفیز- گناد</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>اسپرماتوژنز.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Mey GM, Mahajan KR, DeSilva TM. Neurodegeneration in multiple sclerosis. WIREs Mech Dis 2023; 15: e1583.##2.	Fymat AL. Multiple sclerosis: I. Symptomatology and etiology. J Neurol Psychol Res 2023; 4: 1.##3.	Silveira C, Guedes R, Maia D, Curral R, Coelho R. Neuropsychiatric symptoms of multiple sclerosis: State of the art. Psychiatry Invest 2019; 16: 877-888.##4.	Guo Zh-N, He S-Y, Zhang H-L, Wu J, Yang Y. Multiple sclerosis and sexual dysfunction. Asian J Androl 2012; 14: 530.##5.	Cavalla P, Rovei V, Masera S, Vercellino M, Massobrio M, Mutani R, et al. Fertility in patients with multiple sclerosis: Current knowledge and future perspectives. Neurol Sci 2006; 27: 231-239.##6.	Matuszewska A, Kowalski K, Jawień P, Tomkalski T, Gaweł-Dąbrowska D, Merwid-Ląd A, et al. The hypothalamic-pituitary-gonadal axis in men with schizophrenia. Int J Mol Sci 2023; 24: 6492.##7.	Silveira MA, Zampieri TT, Furigo IC, Abdulkader F, Donato Jr J, Frazão R. Acute effects of somatomammotropin hormones on neuronal components of the hypothalamic-pituitary-gonadal axis. Brain Res 2019; 1714: 210-217.##8.	Trofimenko V, Hotaling JM. Fertility treatment in spinal cord injury and other neurologic disease. Transl Androl Urol 2016; 5: 102-116.##9.	Scandurra C, Rosa L, Carotenuto A, Moccia M, Arena S, Ianniello A, et al. Sexual dysfunction in people with multiple sclerosis: The role of disease severity, illness perception, and depression. J Clin Med 2023; 12: 2215.##10.	Racosta JM, Kimpinski K, Morrow SA, Kremenchutzky M. Autonomic dysfunction in multiple sclerosis. Auton Neurosci 2015; 193: 1-6.##11.	Milosevic A, Janjic MM, Lavrnja I, Savic D, Bozic ID, Tesovic K, et al. The sex-specific patterns of changes in hypothalamic-pituitary-gonadal axis during experimental autoimmune encephalomyelitis. Brain, Behav Immun 2020; 89: 233-244.##12.	Safarinejad MR. Evaluation of endocrine profile, hypothalamic-pituitary-testis axis and semen quality in multiple sclerosis. J Neuroendocrinol 2008; 20: 1368-1375.##13.	Labunets I, Rodnichenko A, Savosko S, Pivneva T. Reaction of different cell types of the brain on neurotoxin cuprizone and hormone melatonin treatment in young and aging mice. Front Cell Neurosci 2023; 17: 1131130.##14.	Ghaiad HR, Abd-Elmawla M, Gad ES, Ahmed K, Abdelmonem M. Modulating miR-146a expression by hydrogen sulfide ameliorates motor dysfunction and axonal demyelination in cuprizone-induced multiple sclerosis. ACS Chem Neurosci 2023; 14: 3047-3058.##15.	Gharighnia S, Omidi A, Ragerdi Kashani I, Sepand MR, Pour Beiranvand Sh. Ameliorative effects of acetyl-L-carnitine on corpus callosum and functional recovery in demyelinated mouse model. Int J Neurosci 2022; 24: 16093.##16.	Paxinos G, Franklin KBJ. Paxinos and Franklin&#039;s the mouse brain in stereotaxic coordinates. 5th Ed. Cambride: Academic press; 2019.##17.	Ziamajidi N, Khajvand-Abedini M, Daei S, Abbasalipourkabir R, Nourian A. Ameliorative effects of vitamins A, C, and E on sperm parameters, testis histopathology, and oxidative stress status in zinc oxide nanoparticle-treated rats. BioMed Res Int 2023; 2023: 4371611.##18.	Fletcher SG, Castro-Borrero W, Remington G, Treadaway K, Lemack GE, Frohman EM. Sexual dysfunction in patients with multiple sclerosis: A multidisciplinary approach to evaluation and management. Nat Clin Pract Urol 2009; 6: 96-107.##19.	Delaney KE, Donovan J. Multiple sclerosis and sexual dysfunction: A need for further education and interdisciplinary care. NeuroRehabilitation 2017; 41: 317-329.##20.	Griswold MD. Spermatogenesis: The commitment to meiosis. Physiol Rev 2016; 96: 1-17.##21.	Tomassini V, Onesti E, Mainero C, Giugni E, Paolillo A, Salvetti M, et al. Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J Neurol Neurosurg Psychiatry 2005; 76: 272-275.##22.	Genç B, Şen S, Aslan K, İncesu L. Volumetric changes in hypothalamic subunits in patients with relapsing remitting multiple sclerosis. Neuroradiology 2023; 65: 899-905.##23.	Plant TM. The neurobiological mechanism underlying hypothalamic GnRH pulse generation: The role of kisspeptin neurons in the arcuate nucleus. F1000Res 2019; 8: 982.##24.	Toolee H, Rastegar T, Solhjoo S, Mortezaee K, Mohammadipour M, Kashani IR, et al. Roles for kisspeptin in proliferation and differentiation of spermatogonial cells isolated from mice offspring when the cells are cocultured with somatic cells. J Cell Biochem 2019; 120: 5042-5054.##25.	Qiu W, Raven S, Wu J-Sh, Bundell Ch, Hollingsworth P, Carroll WM, et al. Hypothalamic lesions in multiple sclerosis. J Neurol Neurosurg Psychiatry 2011; 82: 819-822.##26.	Krementsov DN, Katchy A, Case LK, Carr FE, Davis B, Williams C, et al. Studies in experimental autoimmune encephalomyelitis do not support developmental bisphenol A exposure as an environmental factor in increasing multiple sclerosis risk. Toxicol Sci 2013; 135: 91-102.##27.	Glazer CH, Tøttenborg SS, Giwercman A, Bräuner EV, Eisenberg ML, Vassard D, et al. Male factor infertility and risk of multiple sclerosis: A register-based cohort study. Mult Scler 2018; 24: 1835-1842.##28.	Shaygannejad V, Mirmosayyeb O, Vaheb S, Nehzat N, Ghajarzadeh M. The prevalence of sexual dysfunction and erectile dysfunction in men with multiple sclerosis: A systematic review and meta-analysis. Neurología 2022: S2173-5808(22)00088-8.##29.	Devis M, Stoquart G, Géonet M, London F, van Pesch V. Validation of the French version of the multiple sclerosis intimacy and sexuality questionnaire-19: A preliminary study. Mult Scler Relat Disord 2022; 65: 103986.##30.	Massarotti C, Sbragia E, Gazzo I, Stigliani S, Inglese M, Anserini P. Effect of multiple sclerosis and its treatments on male fertility: Cues for future research. J Clin Med 2021; 10: 5401.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Evaluation of diagnostic value of pelvic MRI in endometriosis in comparison with surgical findings: A cross-sectional study</TitleF>
		<TitleE>مقایسه دقت تشخیصی MRI لگن در اندومتریوز با یافته های جراحی: یک مطالعه مقطعی</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: اندومتریوز یک اختلال ژنیکولوژیک مولتی&#173;فوکال طی دوره باروری است. MRI یک روش تشخیصی ارزشمند برای بیماران اندومتریوز است که می&#173;تواند هم به تنهایی و هم به صورت همراه با TVS استفاده شود.
هدف: این مطالعه با هدف مقایسه دقت تشخیصی MRI لگن در اندومتریوز عمقی با یافته&#173;های جراحی در بیماران مراجعه&#173;کننده به بیمارستان شهید صدوقی یزد در مدت یک سال انجام شد.
مواد و روش &#173;ها: این مطالعه مقطعی بر روی 40 زن مشکوک به اندومتریوز مراجعه&#173;کننده به بیمارستان شهید صدوقی یزد از آبان 1399 تا 1400 انجام شد. بیماران بر اساس علائم بالینی، سابقه&#173;ی جراحی و یا درمان طبی به بخش رادیولوژی جهت مطالعات تکمیلی MRI ارجاع شدند. در نهایت پس از انجام اقدامات تشخیصی لاپاروسکوپیک، یافته&#173;های مشاهده شده در MRI با نتایج پاتولوژیک لاپاروسکوپی مقایسه شد.
نتایج: بر اساس یافته&#173;های تصویربرداری MRI و مقایسه آن با یافته&#173;های لاپاروسکوپیک به عنوان استاندارد طلایی تشخیصی، MRI حساسیتی برابر با 8/94%، و اختصاصیتی برابر با 20% در ارتباط با ضایعات مرتبط با اندومتریوز داشت. همچنین ارزش اخباری مثبت (PPV) تصویر&#173;برداری MRI برابر با 2/90% و ارزش اخباری منفی (NPV) آن برابر با 3/33% است.
نتیجه&#173; گیری: با وجود تلاش&#173;های مستمر برای بهبود روش&#173;های تشخیصی و پیشنهادات جدید مانند اضافه کرده سکانس به مدالیته&#173;های تشخیصی MRI، همچنان لاپاروسکوپی به عنوان بهترین و قابل اعتمادترین روش تشخیصی اندومتریوزیز قرار دارد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Endometriosis is a multifocal gynecologic disorder during the fertility period in women. Magnetic resonance imaging (MRI) is an important diagnostic modality for this disease and can be used either alone or along with transvaginal ultrasonography.
Objective: This study aims to compare the accuracy of pelvis MRI in pelvic deep endometriosis with laparoscopic findings in women referred to Shahid Sadoughi hospital in one year.
Materials and Methods: This cross-sectional study was conducted on 40 women suspicious of endometriosis who referred to Shahid Sadoughi hospital, Yazd, Iran from November 2020-2021. Based on clinical findings and history, participants were referred to the imaging center for pelvic MRI. Finally, the results of MRI and diagnostic laparoscopy were compared with pathologic findings.
Results: The sensitivity and specificity of MRI for pelvic endometriosis were 94.8% and 20%, respectively. Also, the positive predictive value and negative predictive value of MRI were 90.2% and 33.3%, respectively.
Conclusion: Laparoscopy is still the gold standard of endometriosis diagnosis, but MRI with susceptibility-weighted imaging sequence is the best noninvasive diagnostic method.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>55</FPAGE>
			<TPAGE>60</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2023/06/262023/10/242023/10/262023/07/22023/08/202022/06/23
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1401/4/2
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2023/12/252023/12/192024/01/82024/01/132023/12/252023/12/30
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1402/10/9
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Reza</Name>
				<MidName></MidName>
				<Family>Nafisi Moghadam</Family>
				<NameE>Reza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Nafisi Moghadam</FamilyE>
				<Organizations>
				<Organization>Department of Radiology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>nafisi.moghadam@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Fatemeh</Name>
				<MidName></MidName>
				<Family>Tamizi</Family>
				<NameE>Fatemeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Tamizi</FamilyE>
				<Organizations>
				<Organization>Department of Radiology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>fatemeh.tamizi@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Seid Kazem</Name>
				<MidName></MidName>
				<Family>Razavi Ratki</Family>
				<NameE>Seid Kazem</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Razavi Ratki</FamilyE>
				<Organizations>
				<Organization>Department of Radiology, Faculty of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>razavi822@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Amin</Name>
				<MidName></MidName>
				<Family>Nafisi Moghadam</Family>
				<NameE>Amin</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Nafisi Moghadam</FamilyE>
				<Organizations>
				<Organization>Faculty of Medicine, Aliebnabitaleb Azad University, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>aminnafisi1290@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Atiyeh</Name>
				<MidName></MidName>
				<Family>Javaheri</Family>
				<NameE>Atiyeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Javaheri</FamilyE>
				<Organizations>
				<Organization>Department of Obstetrics and Gynecology, Shahid Sadoughi Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>atiyeh56@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Nasim</Name>
				<MidName></MidName>
				<Family>Namiranian</Family>
				<NameE>Nasim</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Namiranian</FamilyE>
				<Organizations>
				<Organization>Diabetes Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>namiranian.nasim@gmail.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Deep infiltrating endometriosis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Magnetic resonance imaging</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Diagnosis</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Laparoscopy</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Sensitivity</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Specificity.</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>اندومتریوز نفوذی عمیق</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>MRI</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>تشخیص</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>لاپاراسکوپی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>حساسیت</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>ویژگی.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Guerriero S, Pascual MA, Ajossa S, Rodriguez I, Zajicek M, Rolla M, et al. Learning curve for ultrasonographic diagnosis of deep infiltrating endometriosis using structured offline training program. Ultrasound Obstet Gynecol 2019; 54: 262-269.##2.	Taniguchi F, Sakamoto Y, Yabuta Y, Azuma Y, Hirakawa E, Nagira K, et al. Analysis of pregnancy outcome and decline of anti‐Müllerian hormone after laparoscopic cystectomy for ovarian endometriomas. J Obstet Gynaecol Res 2016; 42: 1534-1540.##3.	Khodaverdi S, Alebouyeh MR, Sadegi K, Mehdizadehkashi A, Kaveh M, Entezari SR, et al. Superior hypogastric plexus block as an effective treatment method for endometriosis-related chronic pelvic pain: An open-label pilot clinical trial. J Obstet Gynaecol 2021; 41: 966-971.##4.	Burla L, Scheiner D, Hötker AM, Meier A, Fink D, Boss A, et al. Structured manual for MRI assessment of deep infiltrating endometriosis using the ENZIAN classification. Arch Gynecol Obstet 2021; 303: 751-757.##5.	Culley L, Law C, Hudson N, Denny E, Mitchell H, Baumgarten M, et al. The social and psychological impact of endometriosis on women&#039;s lives: A critical narrative review. Hum Reprod Update 2013; 19: 625-639.##6.	Nnoaham KE, Hummelshoj L, Webster P, d&#039;Hooghe T, de Cicco Nardone F, de Cicco Nardone C, et al. Impact of endometriosis on quality of life and work productivity: A multicenter study across ten countries. Fertil Steril 2011; 96: 366-373.##7.	Di Paola V, Manfredi R, Castelli F, Negrelli R, Mehrabi S, Pozzi Mucelli R. Detection and localization of deep endometriosis by means of MRI and correlation with the ENZIAN score. Eur J Radiol 2015; 84: 568-574.##8.	Nisenblat V, Bossuyt PMM, Farquhar C, Johnson N, Hull ML. Imaging modalities for the non-invasive diagnosis of endometriosis. Cochrane Database Syst Rev 2016; 2: Cd009591.##9.	Dunselman GAJ, Vermeulen N, Becker C, Calhaz-Jorge C, D&#039;Hooghe T, De Bie B, et al. ESHRE guideline: Management of women with endometriosis. Hum Reprod 2014; 29: 400-412.##10.	Burla L, Scheiner D, Pierre Samartzis E, Seidel S, Eberhard M, Fink D, et al. The ENZIAN score as a preoperative MRI-based classification instrument for deep infiltrating endometriosis. Arch Gynecol Obstet 2019; 300: 109-116.##11.	Coutinho Jr A, Bittencourt LK, Pires CE, Junqueira F, de Oliveira Lima CMA, Coutinho E, et al. MR imaging in deep pelvic endometriosis: A pictorial essay. Radiographics 2011; 31: 549-567.##12.	Bazot M, Lafont C, Rouzier R, Roseau G, Thomassin-Naggara I, Daraï E. Diagnostic accuracy of physical examination, transvaginal sonography, rectal endoscopic sonography, and magnetic resonance imaging to diagnose deep infiltrating endometriosis. Fertil Steril 2009; 92: 1825-1833.##13.	Siegelman ES, Oliver ER. MR imaging of endometriosis: Ten imaging pearls. Radiographics 2012; 32: 1675-1691.##14.	Krüger K, Behrendt K, Niedobitek-Kreuter G, Koltermann K, Ebert AD. Location-dependent value of pelvic MRI in the preoperative diagnosis of endometriosis. Eur J Obstet Gynecol Reprod Biol 2013; 169: 93-98.##15.	Bianek-Bodzak A, Szurowska E, Sawicki S, Liro M. The importance and perspective of magnetic resonance imaging in the evaluation of endometriosis. Biomed Res Int 2013; 2013: 436589.##16.	Thomeer MG, Steensma AB, van Santbrink EJ, Willemssen FE, Wielopolski PA, Hunink MG, et al. Can magnetic resonance imaging at 3.0-Tesla reliably detect patients with endometriosis? Initial results. J Obstet Gynaecol Res 2014; 40: 1051-1058.##17.	Scardapane A, Lorusso F, Bettocchi S, Moschetta M, Fiume M, Vimercati A, et al. Deep pelvic endometriosis: Accuracy of pelvic MRI completed by MR colonography. Radiol Med 2013; 118: 323-338.##18.	Koninckx PR, Ussia A, Adamyan L, Wattiez A, Donnez J. Deep endometriosis: Definition, diagnosis, and treatment. Fertil Steril 2012; 98: 564-571.##19.	Berger JP, Rhemrev J, Smeets M, Henneman O, English J, Jansen FW. Limited added value of magnetic resonance imaging after dynamic transvaginal ultrasound for preoperative staging of endometriosis in daily practice: A prospective cohort study. J Ultrasound Med 2019; 38: 989-996.##20.	Bielen D, Tomassetti C, Van Schoubroeck D, Vanbeckevoort D, De Wever L, Van den Bosch T, et al. IDEAL study: Magnetic resonance imaging for suspected deep endometriosis assessment prior to laparoscopy is as reliable as radiological imaging as a complement to transvaginal ultrasonography. Ultrasound Obstet Gynecol 2020; 56: 255-266.##21.	Stratton P, Winkel C, Premkumar A, Chow C, Wilson J, Hearns-Stokes R, et al. Diagnostic accuracy of laparoscopy, magnetic resonance imaging, and histopathologic examination for the detection of endometriosis. Fertil Steril 2003; 79: 1078-1085.##22.	Saba L, Guerriero S, Sulis R, Pilloni M, Ajossa S, Melis G, et al. Learning curve in the detection of ovarian and deep endometriosis by using magnetic resonance: Comparison with surgical results. Eur J Radiol 2011; 79: 237-244.##23.	Pin L, Monseau-Thiburce A-C, Ziade-Coularis C, Benjamin A, Menut F, Brun J-L, et al. Exploratory study of the interest of MR susceptibility-weighted imaging for the pre-operative assessment of pelvic endometriosis extent. Eur J Radiol 2019; 118: 245-250.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>The genetically modified human foreskin fibroblast cell line (YhFF#8) stably expressing Cas9 gene: A lab resource report</TitleF>
		<TitleE>دودمانه سلولی تغییر ژنتیکی یافته فیبروبلاست پوست ختنه‌گاه انسان (YhFF#8) با بیان پایدار ژن Cas9: یک گزارش منبع آزمایشگاهی</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: رده&#173;های سلولی بیان&#173;کننده پایدار &#160;Cas9(پروتئین 9 مرتبط با CRISPR) به عنوان ابزار ارزشمندی در تحقیقات ژنتیکی پدیدار شده&#173;اند که کارایی سیستم CRISPR/Cas9 را افزایش داده و روش&#173;های ویرایش ژن را ساده می&#173;کنند. این دودمان&#173;های سلولی امکان ویرایش همزمان چندین ژن را فراهم کرده و زمان کلی ویرایش را کاهش می&#173;دهد.
هدف: این مطالعه با هدف ایجاد یک رده سلولی فیبروبلاست انسانی پایدار با قابلیت تبدیل ژنتیکی به شکل جهش یافته، به عنوان یک مدل سلولی برای یک بیماری ژنتیکی خاص انجام شد. خط سلولی ایجاد شده بررسی مکانیسم&#173;های بیماری، آزمایش درمان&#173;های بالقوه، و به دست آوردن بینش در مورد فرآیندهای مولکولی اساسی را تسهیل می&#173;کند.
مواد و روش&#8204;ها: سلول&#8204;های 293LTV کلیه جنینی انسان (HEK293LTV) برای تولید ذرات شبه&#173;ویروس مورد استفاده قرار گرفتند و سلول&#8204;های فیبروبلاست پوست ختنه&#8204;گاه انسان یزد از سلول&#8204;های دسته 8 (YhFF#8) برای تغییرات ژنتیکی هدف قرار گرفتند. ترانزفکشن سلول&#8204;های HEK293LTV با DNA پلاسمیدی نوترکیب pCDH-Cas9 باعث تولید ذرات شبه&#173;ویروسی شد. سلول&#8204;های YhFF#8 ترانزداکت شده با استفاده از آنتی&#8204;بیوتیک پورومایسین تحت انتخاب قرار گرفتند. درخشش پروتئین فلورسنت سبز (GFP) در سلول&#173;های ترانزداکت شده قبل و بعد از انتخاب آنتی&#173;بیوتیکی سلول&#173;ها تصویربرداری شد. در ضمن سطح بیان نسبی ژن Cas9 در مقایسه با ژن&#173;های GFP و GAPDH با روش کمی (qPCR) تعیین گردید.
یافته&#8204;ها: این مطالعه صحت توالی کاست ژن Cas9 و فعالیت رونویسی آن را تأیید کرد. سلول&#8204;های YhFF#8 ترانزداکت شده، فلورسانس سبز نشان داده و با انتخاب آنتی&#8204;بیوتیکی که منجر به خالص&#173;سازی تقریباً 100% سلول&#8204;های تبدیل شده شد. بیان ژن GFP با استفاده از میکروسکوپ فلورسانس، امکان رصد زنده سلول&#8204;های YhFF#8-Cas9-GFP-PuroR را در محیط کشت را فراهم کرد.
نتیجه&#8204;گیری: سلول&#8204;های YhFF#8-Cas9-GFP-PuroR، برچسب&#8204;گذاری&#8204;شده و مستعد برای انجام فرایند ویرایش ژنومی، منبع بهینه&#8204;ای برای تولید رده&#173;&#8204;های سلول&#8204;های بنیادی پرتوان القایی برای تحقیقات زیست&#8204;پزشکی آینده فراهم می&#8204;کنند.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Stable Cas9 (CRISPR-associated protein 9)-expressing cell lines have emerged as valuable tools in genetic research, enhancing the efficiency of the CRISPR/Cas9 system and streamlining gene editing procedures. These cell lines enable simultaneous editing of multiple genes and reduce the overall editing time.
Objective: This study aimed to develop a stable human fibroblast cell line capable of genetic conversion into a mutant form, serving as a cellular model for a specific genetic disease. The established cell line facilitates investigation of disease mechanisms, testing of potential treatments, and gaining insights into underlying molecular processes.
Materials and Methods: Human embryonic kidney 293LTV cells were used to produce pseudo-virus particles, while Yazd human foreskin fibroblasts batch 8 (YhFF#8) cells were targeted for genetic modification. Transfection of human embryonic kidney 293LTV cells with pCDH-Cas9 plasmid DNA generated pseudo-viral particles. YhFF#8 cells were transduced and selected using antibiotics. Green fluorescent protein (GFP) detection confirmed successful transduction and selection. Relative expression levels of the Cas9 gene were determined by quantitative polymerase chain reaction.
Results: The study validated the fidelity of the Cas9 gene cassette sequence and its transcriptional activity. Transduced YhFF#8 cells exhibited green fluorescence, with antibiotic selection resulting in nearly 100% transduced cells. A reporter GFP gene enabled real-time monitoring of YhFF#8-Cas9-GFP-PuroR cells using fluorescence microscopy.
Conclusion: YhFF#8-Cas9-GFP-PuroR cells, labeled and susceptible to genomic editing, provide an optimal source for generating induced pluripotent stem cell lines for future biomedical research.</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>61</FPAGE>
			<TPAGE>68</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2023/06/262023/10/242023/10/262023/07/22023/08/202022/06/232023/07/24
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1402/5/2
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2023/12/252023/12/192024/01/82024/01/132023/12/252023/12/302024/01/10
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1402/10/20
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Farzad</Name>
				<MidName></MidName>
				<Family>Soheilipour</Family>
				<NameE>Farzad</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Soheilipour</FamilyE>
				<Organizations>
				<Organization>Stem Cell Biology Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. Department of Biology, Faculty of Basic Sciences, Gonbad Kavous University, Gonbad Kavous, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>soheilipourfarzad@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Sohrab</Name>
				<MidName></MidName>
				<Family>Boozarpour</Family>
				<NameE>Sohrab</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Boozarpour</FamilyE>
				<Organizations>
				<Organization>Department of Biology, Faculty of Basic Sciences, Gonbad Kavous University, Gonbad Kavous, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>so.boozarpour@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Shiva</Name>
				<MidName></MidName>
				<Family>Aghaei</Family>
				<NameE>Shiva</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Aghaei</FamilyE>
				<Organizations>
				<Organization>Stem Cell Biology Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>aghaei.shiva@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Ehsan</Name>
				<MidName></MidName>
				<Family>Farashahi Yazd</Family>
				<NameE>Ehsan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Farashahi Yazd</FamilyE>
				<Organizations>
				<Organization>Stem Cell Biology Research Center, Yazd Reproductive Sciences Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>ehsanfarashahi@ssu.ac.ir</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Fibroblasts</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Cell line</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Genetic transduction</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>CRISPR-Cas9.</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>فیبروبلاست ها</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>دودمانه سلولی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>ترانزداکشن ژنتیکی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>کریسپر-کاس 9.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Carrillo-Ávila JA, Catalina P, Aguilar-Quesada R. Quality control of cell lines using DNA as target. DNA 2022; 2: 44-55.##2.	Capes-Davis A, Bairoch A, Barrett T, Burnett EC, Dirks WG, Hall EM, et al. Cell lines as biological models: Practical steps for more reliable research. Chem Res Toxicol 2019; 32: 1733-1736.##3.	Dumont J, Euwart D, Mei B, Estes S, Kshirsagar R. Human cell lines for biopharmaceutical manufacturing: History, status, and future perspectives. Crit Rev Biotechnol 2016; 36: 1110-1122.##4.	Genzel Y. Designing cell lines for viral vaccine production: Where do we stand? Biotechnol J 2015; 10: 728-740.##5.	Peng Y, Ma A, Xiao Zh, Hao J, Feng R, Wang Ch, et al. Technical specifications for ethics review of human stem cell research. Cell Prolif 2023: e13556.##6.	Xu Y, Li Zh. CRISPR-Cas systems: Overview, innovations and applications in human disease research and gene therapy. Comput Struct Biotechnol J 2020; 18: 2401-2415.##7.	Caneparo Ch, Baratange C, Chabaud S, Bolduc S. Conditioned medium produced by fibroblasts cultured in low oxygen pressure allows the formation of highly structured capillary-like networks in fibrin gels. Sci Rep 2020; 10: 9291.##8.	Fernandes IR, Russo FB, Pignatari GC, Evangelinellis MM, Tavolari S, Muotri AR, et al. Fibroblast sources: Where can we get them? Cytotechnology 2016; 68: 223-228.##9.	Mesdom P, Colle R, Lebigot E, Trabado S, Deflesselle E, Fève B, et al. Human dermal fibroblast: A promising cellular model to study biological mechanisms of major depression and antidepressant drug response. Curr Neuropharmacol 2020; 18: 301-318.##10.	Han X, Liu Z, Jo MC, Zhang K, Li Y, Zeng Z, et al. CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation. Sci Adv 2015; 1: e1500454.##11.	DeWitt MA, Corn JE, Carroll D. Genome editing via delivery of Cas9 ribonucleoprotein. Methods 2017; 121-122: 9-15.##12.	Suchý T, Kaczmarek I, Maricic T, Zieschang C, Schöneberg T, Thor D, et al. Evaluating the feasibility of Cas9 overexpression in 3T3-L1 cells for generation of genetic knock-out adipocyte cell lines. Adipocyte 2021; 10: 631-645.##13.	Javaid N, Choi S. CRISPR/Cas system and factors affecting its precision and efficiency. Front Cell Dev Biol 2021; 9: 761709.##14.	Aregger M, Chandrashekhar M, Tong AHY, Chan K, Moffat J. Pooled lentiviral CRISPR-Cas9 screens for functional genomics in Mammalian cells. Methods Mol Biol 2018; 1869: 169-188. ##15.	Yu H, Wu Zh, Chen X, Ji Q, Tao Sh. CRISPR-CBEI: A designing and analyzing tool kit for cytosine base editor-mediated gene inactivation. MSystems 2020; 5: e00350-20.##16.	Dong W, Kantor B. Lentiviral vectors for delivery of gene-editing systems based on CRISPR/Cas: Current state and perspectives. Viruses 2021; 13: 1288.##17.	Liao JQ, Zhou G, Zhou Y. Generation of monoclonal iPSC lines with stable Cas9 expression and high Cas9 activity. Methods Mol Biol 2022; 2454: 575-588.##18.	Aubrey BJ, Kelly GL, Kueh AJ, Brennan MS, O&#039;Connor L, Milla L, et al. An inducible lentiviral guide RNA platform enables the identification of tumor-essential genes and tumor-promoting mutations in vivo. Cell Rep 2015; 10: 1422-1432.##19.	Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.##20.	Fernandez JP, Vejnar ChE, Giraldez AJ, Rouet R, Moreno-Mateos MA. Optimized CRISPR-Cpf1 system for genome editing in zebrafish. Methods 2018; 150: 11-18.##21.	Lino CA, Harper JC, Carney JP, Timlin JA. Delivering CRISPR: A review of the challenges and approaches. Drug Deliv 2018; 25: 1234-1257.##22.	Campa CC, Weisbach NR, Santinha AJ, Incarnato D, Platt RJ. Multiplexed genome engineering by Cas12a and CRISPR arrays encoded on single transcripts. Nat Methods 2019; 16: 887-893. ##23.	Lo ChA, Greben AW, Chen BE. Generating stable cell lines with quantifiable protein production using CRISPR/Cas9-mediated knock-in. Biotechniques 2017; 62: 165-174. ##24.	Hajizadeh-Tafti F, Golzadeh J, Farashahi-Yazd E, Heidarian-Meimandi H, Aflatoonian B. Established Yazd human foreskin fibroblast lines (#8, #17, and #18) displaying similar characteristics to mesenchymal stromal cells: A lab resources report. Int J Reprod BioMed 2022; 20: 519-528.##25.	Ryø LB, Thomsen EA, Mikkelsen JG. Production and validation of lentiviral vectors for CRISPR/Cas9 delivery. Methods Mol Biol 2019; 1961: 93-109.##26.	Wang X, Xu Zh, Tian Zh, Zhang X, Xu D, Li Q, et al. The EF-1α promoter maintains high-level transgene expression from episomal vectors in transfected CHO-K1 cells. J Cell Mol Med 2017; 21: 3044-3054.##27.	Wen J, Wu J, Cao T, Zhi S, Chen Y, Aagaard L, et al. Methylation silencing and reactivation of exogenous genes in lentivirus-mediated transgenic mice. Transgenic Res 2021; 30: 63-76. ##28.	Ellis J. Silencing and variegation of gammaretrovirus and lentivirus vectors. Hum Gene Ther 2005; 16: 1241-1246.##29.	Schlesinger Sh, Goff SP. Silencing of proviruses in embryonic cells: Efficiency, stability and chromatin modifications. EMBO Rep 2013; 14: 73-79.##30.	Herbst F, Ball CR, Tuorto F, Nowrouzi A, Wang W, Zavidij O, et al. Extensive methylation of promoter sequences silences lentiviral transgene expression during stem cell differentiation in vivo. Mol Ther 2012; 20: 1014-1021.##31.	Khacho M, Mekhail K, Pilon-Larose K, Pause A, Côté J, Lee S. eEF1A is a novel component of the mammalian nuclear protein export machinery. Mol Biol Cell 2008; 19: 5296-5308.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>


	<ARTICLE> 
		<TitleF>Aspirin administration from early pregnancy versus initiation after 11 weeks of gestation for prevention of pre-eclampsia in high-risk pregnant women: Study protocol for randomized controlled trial</TitleF>
		<TitleE>مقایسه ی تجویز آسپرین از اوایل باداری نسبت به شروع مصرف آن از بعد از 11 هفته در پیشگیری از پره اکلامپسی در زنان باردار پرخطر: پروتکل یک مطالعه کارآزمایی بالینی</TitleE>
		<TitleLang_ID>2</TitleLang_ID>
		<ABSTRACTS>
			<ABSTRACT>
			<Language_ID>1</Language_ID>
			<CONTENT>مقدمه: پره&#173;اکلامپسی یک اختلال چند ارگانی است که 5-2% زنان باردار تحت تأثیر قرا می&#173;دهد. توصیه&#173;های ارایه شده برای شروع آسپرین در زنان پرخطر پس از هفته 11 بارداری است.
هدف: ما پروتکلی را برای بررسی اثربخشی مصرف آسپرین از اوایل بارداری ارایه می&#173;دهیم که یک کارآزمایی تصادفی کنترل شده برای ارزیابی اینکه آیا آسپرین با دوز کم تجویز شده از اوایل بارداری شیوع پره&#173;اکلامپسی زودرس و دیررس را کاهش می&#173;دهد. علاوه بر این برای مقایسه&#173;ی اثربخشی تجویز آسپرین قبل و بعد از 11 هفته در کاهش وقوع پره&#173;اکلامپسی؟
مواد و روش &#173;ها: کلیه حاملگی&#173;های در معرض خطر پره&#173;اکلامپسی با توجه به سابقه جمعیت&#173;شناختی و مامایی که به کلینیک مادر و جنین بیمارستان دانشگاه تهران مراجعه می&#173;کنند برای شرکت در این کارآزمایی دعوت می&#173;شوند. نتایج (پیامدهای) بارداری و نوزادان جمع&#173;آوری و تجزیه و تحلیل خواهد شد. اولین ثبت نام برای مطالعه پایلوت از شرکت&#173;کنندگان پرخطر برای پره&#173;اکلامپسی از ژانویه 2023 بوده است. علاوه بر این ثبت نام در کارآزمایی اصلی از اکتبر 2023 آغاز خواهد شد.</CONTENT>
			</ABSTRACT>
			<ABSTRACT>
			<Language_ID>2</Language_ID>
			<CONTENT>Background: Pre-eclampsia (PE) is a multiorgan disorder that affects 2-5% of all pregnant women. Present recommendations for when to start aspirin in high-risk women are after 11 wk of gestation.
Objective: We present a protocol to investigate the effectiveness of aspirin use from early pregnancy, which is a randomized controlled trial to assess whether prescribed low-dose aspirin from early pregnancy reduces the prevalence of early and late-onset PE. Additionally, to compare the effectiveness of aspirin administration before and after 11 wk in reducing the occurrence of PE?
Materials and Methods: All pregnancies at risk of PE, according to demographic and midwifery history, who are referred to the Maternal-Fetal Clinic of Tehran University hospital, Tehran, Iran were invited to take part in the trial. The outcomes of pregnancy and newborns will be gathered and analyzed. The first registration for the pilot study was in January 2023, and the participants were recognized as high-risk for PE. In addition, enrollment in the main study will begin as of October 2023. 
&#160;</CONTENT>
			</ABSTRACT>
		</ABSTRACTS>

		<PAGES>
			<PAGE>
			<FPAGE>69</FPAGE>
			<TPAGE>80</TPAGE>
			</PAGE>
		</PAGES>

		<RECEIVE_DATE>
			2023/06/262023/10/242023/10/262023/07/22023/08/202022/06/232023/07/242023/09/12
		</RECEIVE_DATE>

		<RECEIVE_DATE_FA>
			1402/6/21
		</RECEIVE_DATE_FA>

		<ACCEPT_DATE>
			2023/12/252023/12/192024/01/82024/01/132023/12/252023/12/302024/01/102023/12/25
		</ACCEPT_DATE>

		<ACCEPT_DATE_FA>
			1402/10/4
		</ACCEPT_DATE_FA>

		<AUTHORS>
			<AUTHOR>
				<Name>Sedigheh</Name>
				<MidName></MidName>
				<Family>Hantoushzadeh</Family>
				<NameE>Sedigheh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hantoushzadeh</FamilyE>
				<Organizations>
				<Organization>Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>hantoushzadeh@tums.ac.ir</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Arezoo</Name>
				<MidName></MidName>
				<Family>Behzadian</Family>
				<NameE>Arezoo</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Behzadian</FamilyE>
				<Organizations>
				<Organization>Department of Perinatology, Vali-E-Asr Hospital, Imam Khomeini Hospital Complex, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>dr.a.behzadian56@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mohammad Mehdi</Name>
				<MidName></MidName>
				<Family>Hasheminejad</Family>
				<NameE>Mohammad Mehdi</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hasheminejad</FamilyE>
				<Organizations>
				<Organization>Iran University of Medical Sciences, Tehran, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>dr.m.mehdi79@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Faezeh</Name>
				<MidName></MidName>
				<Family>Hasheminejad</Family>
				<NameE>Faezeh</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Hasheminejad</FamilyE>
				<Organizations>
				<Organization>Asklepios Psychiatry Lower Saxony GmbH, Asklepios Specialist Clinic, Gottingen, Germany.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>Faezehasheminjd@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Alireza</Name>
				<MidName></MidName>
				<Family>Helal Birjandi</Family>
				<NameE>Alireza</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Helal Birjandi</FamilyE>
				<Organizations>
				<Organization>Hannover Medical School, Clinic for Urology, Hannover, Germany.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>helalbirjandi.alireza@mh-hannovet.de</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Mojtaba</Name>
				<MidName></MidName>
				<Family>Akbari</Family>
				<NameE>Mojtaba</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Akbari</FamilyE>
				<Organizations>
				<Organization>Isfahan Endocrine and Metabolism Research Center, Isfahan University of Medicine Sciences, Isfahan, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>akbari.epi@gmail.com</Email>
				</EMAILS>
			</AUTHOR>

			<AUTHOR>
				<Name>Marjan</Name>
				<MidName></MidName>
				<Family>Ghaemi</Family>
				<NameE>Marjan</NameE>
				<MidNameE></MidNameE>
				<FamilyE>Ghaemi</FamilyE>
				<Organizations>
				<Organization>Vali-E-Asr Hospital, Imam Khomeini Hospital Complex, Iran.</Organization>
				</Organizations>
				<Countries>
				<Country>ایران</Country>
				</Countries>
				<EMAILS>
				<Email>marjan_ghaemi@yahoo.com</Email>
				</EMAILS>
			</AUTHOR>
		</AUTHORS>


		<KEYWORDS>
			<KEYWORD>
				<KeyText>Pre-eclampsia</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Aspirin</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Color doppler ultrasonography</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Pregnancy</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>First trimester</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>Pregnancy-associated plasma protein-A.</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>پره اکلامپسی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>آسپرین</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سونوگرافی داپلر رنگی</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>بارداری</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>سه ماهه اول</KeyText>
			</KEYWORD>

			<KEYWORD>
				<KeyText>پروتئین پلاسمای مرتبط با بارداری-A.</KeyText>
			</KEYWORD>
		</KEYWORDS>

		<REFRENCES>
			<REFRENCE>
				<REF>1.	Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int J Gynaecol Obstet 2019; 145 (Suppl.): 1-33.##2.	Brosens I, Pijnenborg R, Vercruysse L, Romero R. The “great obstetrical syndrome” are associated with disorders of deep placentation. Am J Obstet Gynecol 2010; 204: 193-201.##3.	Zuo Q, Zou Y, Huang Sh, Wang T, Xu Y, Zhang T, et al. Aspirin reduces sFlt-1-mediated apoptosis of trophoblast cells in preeclampsia. Mol Hum Reprod 2021; 27: gaaa089.##4.	Benigni A, Gregorini G, Frusca T, Chiabrando C, Ballerini S, Valcamonico A, et al. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for ppregnancy-induced hypertension. N Engl J Med 1989; 321: 357-362.##5.	Espinoza J, Romero R, Kim YM, Kusanovic JP, Hassan S, Erez O, et al. Normal and abnormal transformation of the spiral arteries during pregnancy. J Perinat Med 2006; 34: 447-458.##6.	Rolnik DL, Wright D, Poon LC, O’Gorman N, Syngelaki A, de Paco Matallana C, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med 2017; 377: 613-622.##7.	Hoffman MK, Goudar SS, Kodkany BS, Metgud M, Somannavar M, Okitawutshu J, et al. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): A randomised, double-blind, placebo-controlled trial. Lancet 2020; 395: 285-293.##8.	Roberge S, Sibai B, McCaw-Binns A, Bujold E. Low-dose aspirin in early gestation for prevention of preeclampsia and small-for-gestational-age neonates: Meta-analysis of large randomized trials. Am J Perinatol 2016; 33: 781-785.##9.	Li C, Raikwar NS, Santillan MK, Santillan DA, Thomas CP. Aspirin inhibits expression of sFLT1 from human cytotrophoblasts induced by hypoxia, via cyclo-oxygenase 1. Placenta 2015; 36: 446-453.##10.	Panagodage Sh, Yong HEJ, Da Silva Costa F, Borg AJ, Kalionis B, Brennecke ShP, et al. Low-dose acetylsalicylic acid treatment modulates the production of cytokines and improves trophoblast function in an in vitro model of early-onset preeclampsia. Am J Pathol 2016; 186: 3217-3224.##11.	Henderson JT, Whitlock EP, O&#039;Connor E, Senger CA, Thompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: A systematic evidence review for the U.S. preventive services task force. Ann Intern Med 2014; 160: 695-703.##12.	Ahrens KA, Silver RM, Mumford SL, Sjaarda LA, Perkins NJ, Wactawski-Wende J, et al. Complications and safety of preconception low-dose aspirin among women with prior pregnancy losses. Obstet Gynecol 2016; 127: 689-698.##13.	US Preventive Services Task Force, Davidson KW, Barry MJ, Mangione CM, Cabana M, Caughey AB, et al. Aspirin use to prevent preeclampsia and related morbidity and mortality: US preventive services task force recommendation statement. JAMA 2021; 326: 1186-1191.##14.	Roberts JM, King TL, Barton JR, Beck S, Bernstein IM, Buck TE, et al. Care plan for individuals at risk for preeclampsia: Shared approach to education, strategies for prevention, surveillance, and follow-up.3. Am J Obstet Gynecol 2023; 229: 193-213.##15.	Poon L, Maiz N, Valencia C, Plasencia W, Nicolaides K. First‐trimester maternal serum pregnancy‐associated plasma protein‐A and pre‐eclampsia. Ultrasound Obstet Gynecol 2009; 33: 23-33.##16.	Martin AM, Bindra R, Curcio P, Cicero S, Nicolaides KH. Screening for pre‐eclampsia and fetal growth restriction by uterine artery Doppler at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 2001; 18: 583-586.##17.	Harrington K, Carpenter R, Goldfrad C, Campbell S. Transvaginal doppler ultrasound of the uteroplacental circulation in the early prediction of pre‐eclampsia and intrauterine growth retardation. Br J Obstet Gynaecol 1997; 104: 674-681.##18.	Brown MA, Magee LA, Kenny LC, Karumanchi SA, McCarthy FP, Saito S, et al. Hypertensive disorders of pregnancy: ISSHP classification, diagnosis, and management recommendations for international practice. Hypertension 2018; 72: 24-43.##19.	Cotechini T, Komisarenko M, Sperou A, Macdonald-Goodfellow Sh, Adams MA, Graham ChH. Inflammation in rat pregnancy inhibits spiral artery remodeling leading to fetal growth restriction and features of preeclampsia. J Exp Med 2014; 211: 165-179.##20.	Lyall F. Priming and remodelling of human placental bed spiral arteries during pregnancy- a review. Placenta 2005; 26: S31-S36.##21.	Roberge S, Bujold E, Nicolaides KH. Aspirin for the prevention of preterm and term preeclampsia: Systematic review and metaanalysis. Am J Obstet Gynecol 2018; 218: 287-293.##22.	Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: A meta-analysis. Obstet Gynecol 2010; 116: 402-414.##23.	Vainio M, Kujansuu E, Koivisto A-M, Maenpaa J. Bilateral notching of uterine arteries at 12-14 weeks of gestation for prediction of hypertensive disorders of pregnancy. Acta Obstet Gynecol Scand 2005; 84: 1062-1067.##24.	Sahin S, Ozakpinar OB, Eroglu M, Tulunay A, Ciraci E, Uras F, et al. The impact of platelet functions and inflammatory status on the severity of preeclampsia. J Matern Fetal Neonatal Med 2015; 28: 643-648.## ##</REF>
			</REFRENCE>
		</REFRENCES>

	</ARTICLE>

</ARTICLES>

</JOURNAL>
</XML>
